Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin

BackgroundWe compared the efficacies of vildagliptin (50 mg twice daily) relative to pioglitazone (15 mg once daily) as an add-on treatment to metformin for reducing glycosylated hemoglobin (HbA1c) levels in Korean patients with type 2 diabetes.MethodsThe present study was a multicenter, randomized,...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Jong Ho Kim, Sang Soo Kim, Hong Sun Baek, In Kyu Lee, Dong Jin Chung, Ho Sang Sohn, Hak Yeon Bae, Mi Kyung Kim, Jeong Hyun Park, Young Sik Choi, Young Il Kim, Jong Ryeal Hahm, Chang Won Lee, Sung Rae Jo, Mi Kyung Park, Kwang Jae Lee, In Joo Kim
格式: Artigo
語言:Inglês
出版: Korean Diabetes Association 2016-04-01
叢編:Diabetes & Metabolism Journal
主題:
Dipeptidyl peptidase 4 inhibitor
Metformin
Thiazolidinediones
在線閱讀:https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-230.pdf
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍